Parametrica Management LTD Prothena Corp Public LTD CO Transaction History
Parametrica Management LTD
- $69.3 Million
- Q1 2024
Shares
2 transactions
Others Institutions Holding PRTA
# of Institutions
187Shares Held
45.4MCall Options Held
119KPut Options Held
144K-
Eco R1 Capital, LLC San Francisco, CA11.6MShares$235 Million8.18% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.2MShares$85.1 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA3.75MShares$76 Million0.02% of portfolio
-
Black Rock Inc. New York, NY3.72MShares$75.3 Million0.0% of portfolio
-
State Street Corp Boston, MA3.47MShares$70.4 Million0.0% of portfolio
About PROTHENA CORP PUBLIC LTD CO
- Ticker PRTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,922,800
- Market Cap $951M
- Description
- Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...